Consequently, key hedge funds have been driving this bullishness. Polar Capital, led by Brian Ashford-Russell and Tim Woolley, created the most outsized position in Trillium Therapeutics Inc. (NASDAQ:TRIL). Polar Capital had $0.5 million invested in the company at the end of the quarter.
Let’s also examine hedge fund activity in other stocks similar to Trillium Therapeutics Inc. (NASDAQ:TRIL). We will take a look at Demand Media Inc (NYSE:DMD), Skyline Corporation (NYSE:SKY), Uranium Energy Corp. (NYSEAMEX:UEC), and Navios Maritime Partners L.P. (NYSE:NMM). This group of stocks’ market valuations resemble TRIL’s market valuation.
|Ticker||No of HFs with positions||Total Value of HF Positions (x1000)||Change in HF Position|
As you can see these stocks had an average of 4 hedge funds with bullish positions and the average amount invested in these stocks was $12 million. That figure was $22 million in TRIL’s case. Demand Media Inc (NYSE:DMD) is the most popular stock in this table. On the other hand Navios Maritime Partners L.P. (NYSE:NMM) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks Trillium Therapeutics Inc. (NASDAQ:TRIL) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.